文献速递脑血管病神经重症与神经感染

可溶性ST2与脑实质出血后功能结局、血肿周围水肿及免疫反应的相关性

Association of Soluble ST2 With Functional Outcome, Perihematomal Edema, and Immune Response After Intraparenchymal Hemorrhage.
PubMed 文献 · Neurology · 2022-12-22

研究纳入2个中心前瞻性收集的55例深部脑实质出血患者,在发病36小时内检测血可溶性ST2(sST2)及免疫细胞,用系列CT测量血肿体积和血肿周围水肿(PHE)。sST2预测不良结局的曲线下面积为0.763(95%CI 0.632-0.894),最佳截断值61.8 ng/mL(p<0.001);校正ICH评分后sST2仍为独立预测因子(校正OR 2.53,95%CI 1.03-6.19,p=0.042)。高sST2患者PHE随时间增加更大(β=1.07,95%CI 0.51-1.63,p<0.001),且与外周固有免疫反应偏移相关(单核细胞和自然杀伤细胞占比68.6%±5.1% vs 47.5%±4.0%,p=0.003)。

要点

  • sST2预测深部脑实质出血后90天不良结局的AUC为0.763(95%CI 0.632-0.894),最佳截断值61.8 ng/mL(p<0.001)。
  • 校正ICH评分后,sST2仍为不良结局的独立预测因子(校正OR 2.53,95%CI 1.03-6.19,p=0.042)。
  • 高sST2患者血肿周围水肿随时间增加更大(β=1.07,95%CI 0.51-1.63,p<0.001)。

核心结论

  • 研究结果表明,升高的sST2将外周固有免疫反应与脑实质出血后血肿周围水肿体积及结局联系起来。
  • 该认识与未来研究相关,这些研究旨在识别免疫介导损伤风险最高的脑实质出血患者或通过靶向干预限制损伤。

研究设计与样本

  • 利用2个中心前瞻性收集的队列,纳入发病36小时内的深部脑实质出血患者,采血检测sST2和免疫细胞,用系列CT测量血肿体积和血肿周围水肿。
  • 共纳入55例患者,入院格拉斯哥昏迷量表评分中位数14分(四分位距9-15),脑出血评分1分(四分位距1-2),血肿体积8.6 mL(四分位距3.4-13.8 mL)。
  • 采用线性混合效应模型分析sST2与血肿周围水肿随时间的关系,用流式细胞术识别与sST2相关的免疫细胞群体变化,用免疫组化检测人脑组织血肿周围区域表达ST2的细胞。
  • 良好结局定义为90天改良Rankin量表评分0-3分。

主要发现

  • 受试者工作特征曲线分析发现sST2水平预测不良结局的曲线下面积为0.763(95%CI 0.632-0.894),约登最佳截断值为61.8 ng/mL(p<0.001)。
  • 校正ICH评分后,sST2仍为独立预测因子(校正比值比2.53,95%CI 1.03-6.19,p=0.042)。
  • 测量血肿周围水肿发现,高sST2患者随时间推移水肿体积更大(β=1.07,95%CI 0.51-1.63,p<0.001)。
  • 高sST2与向固有外周免疫反应偏移相关(单核细胞和自然杀伤细胞;68.6%±5.1% vs 47.5%±4.0%;p=0.003)。

关键数值与推荐

  • sST2预测不良结局的AUC为0.763(95%CI 0.632-0.894),约登最佳截断值61.8 ng/mL(p<0.001)。
  • 校正ICH评分后sST2的校正OR为2.53(95%CI 1.03-6.19,p=0.042)。
  • 高sST2与水肿体积随时间变化的β值为1.07(95%CI 0.51-1.63,p<0.001)。
  • 高sST2组单核细胞和自然杀伤细胞占比68.6%±5.1%,vs 非高sST2组47.5%±4.0%(p=0.003)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Perihematomal edema (PHE) contributes to poor outcome after deep intraparenchymal hemorrhage (IPH), which is characterized by neuroinflammation and an influx of peripherally derived innate immune cells. We previously identified soluble ST2 (sST2) as a candidate for immune-mediated secondary brain injury. Leveraging prospectively collected cohorts from 2 centers, we sought to determine whether sST2 was associated with functional outcome, PHE, and the immune response following IPH. METHODS: Patients with deep IPH were enrolled within 36 hours of ictus, and blood was collected for sST2 and immune cell measurement. Hematoma volume and PHE were measured on serial CT scans. Good outcome was defined as a modified Rankin Scale score of 0-3 at 90 days. Linear mixed-effects models were used to analyze the relationship between sST2 and PHE over time. Flow cytometry was used to identify shifts in immune cell populations associated with sST2. Immunohistochemistry of human brain tissue was used to identify ST2-expressing cells in the perihematomal region. RESULTS: The 55 included patients had a median admission Glasgow Coma Scale score of 14 (interquartile range [IQR] 9-15), an intracerebral hemorrhage (ICH) score of 1 (IQR 1-2), and a hematoma volume of 8.6 mL (IQR 3.4-13.8 mL). Receiver operating curve analysis found the sST2 level to be predictive of poor outcome with an area under the curve of 0.763 (95% CI 0.632-0.894) and Youden optimum cut point of 61.8 ng/mL (p < 0.001). sST2 remained an independent predictor after adjustment for ICH score (adjusted odds ratio 2.53, 95% CI 1.03-6.19, p = 0.042). Measurement of PHE found those patients with high sST2 to have greater edema volume over time (β = 1.07, 95% CI 0.51-1.63, p < 0.001). High sST2 was associated with a shift toward an innate peripheral immune response (monocytes and natural killer cells; 68.6% ± 5.1% vs 47.5% ± 4.0%; p = 0.003). DISCUSSION: Our findings demonstrate that elevated sST2 links the peripheral innate immune response to PHE volume and outcome after IPH. This knowledge is relevant to future studies that seek to identify patients with IPH at highest risk for immune-mediated injury or limit injury through targeted interventions.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Bevers MB, Booraem C, Li K, et al. Association of Soluble ST2 With Functional Outcome, Perihematomal Edema, and Immune Response After Intraparenchymal Hemorrhage. Neurology. 2022. PMID: 36549913. doi:10.1212/WNL.0000000000206764

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。